StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.43+0.01 (+0.70%)

Close on Nov 18, 2026Market cap $53.52MP/E –Yield –

Tenax Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Tenax Therapeutics's shares outstanding was 51M at Jun 30, 2026. For fiscal 2025 it was 39M, up 156.8% from the year before. Over ten years it grew 84.0% a year on average. The highest annual figure on record is 39M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202539M+156.8%
FY2024Dec 31, 202415M+6046.9%
FY2023Dec 31, 20230M-98.8%
FY2021Dec 31, 202121M+98.5%
FY2020Dec 31, 202010M+67.3%
FY2019Dec 31, 20196M+295.9%
FY2018Dec 31, 20182M+10.9%
FY2017Dec 31, 20171M+0.5%
FY2015Apr 30, 20151M+199.9%
FY2014Apr 30, 20140M+432.2%
FY2013Apr 30, 20130M+26.8%
FY2012Apr 30, 20120M+18.9%
FY2011Apr 30, 20110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 202651M+28.5%
Q1 FY2026CQ1 2026Mar 31, 202645M+23.6%
Q4 FY2025CQ4 2025Dec 31, 202541M+93.4%
Q3 FY2025CQ3 2025Sep 30, 202540M+1929.4%
Q2 FY2025CQ2 2025Jun 30, 202540M+3145.9%
Q1 FY2025CQ1 2025Mar 31, 202537M+44.9%
Q3 FY2024CQ3 2024Sep 30, 202421M-16.0%
Q2 FY2024CQ2 2024Jun 30, 20242M-88.6%
Q1 FY2024CQ1 2024Mar 31, 20241M-91.6%
Q4 FY2021CQ4 2021Dec 31, 202125M+99.0%
Q3 FY2021CQ3 2021Sep 30, 202125M+102.8%
Q2 FY2021CQ2 2021Jun 30, 202117M+84.4%
Q1 FY2021CQ1 2021Mar 31, 202115M+108.1%
Q4 FY2020CQ4 2020Dec 31, 202013M+88.1%
Q3 FY2020CQ3 2020Sep 30, 202012M+84.4%
Q2 FY2020CQ2 2020Jun 30, 20209M+46.3%
Q1 FY2020CQ1 2020Mar 31, 20207M+42.7%
Q4 FY2019CQ4 2019Dec 31, 20197M+251.5%
Q3 FY2019CQ3 2019Sep 30, 20197M+361.0%
Q2 FY2019CQ2 2019Jun 30, 20196M+339.3%
Q1 FY2019CQ1 2019Mar 31, 20195M+243.5%
Q4 FY2018CQ4 2018Dec 31, 20182M+36.0%
Q3 FY2018CQ3 2018Sep 30, 20181M+3.6%
Q2 FY2018CQ2 2018Jun 30, 20181M+3.0%
Q1 FY2018CQ1 2018Mar 31, 20181M+1.1%
Q4 FY2017CQ4 2017Dec 31, 20171M+0.4%
Q3 FY2017CQ3 2017Sep 30, 20171M+0.4%
Q2 FY2017CQ2 2017Jun 30, 20171M–
Q1 FY2017CQ1 2017Mar 31, 20171M–
Q4 FY2015CQ1 2015Apr 30, 20151M–
Q3 FY2015CQ4 2014Jan 31, 20151M–

More Tenax Therapeutics figures

See a number that looks wrong?